Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 27.78
(-0.71%)
CNY 27.78
(-0.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.84 Billion CNY | 33.09% |
| 2022 | 9.65 Billion CNY | 19.26% |
| 2021 | 8.09 Billion CNY | 172.06% |
| 2020 | 2.97 Billion CNY | 41.87% |
| 2019 | 2.09 Billion CNY | -8.17% |
| 2018 | 2.28 Billion CNY | 19.63% |
| 2017 | 1.9 Billion CNY | 83.35% |
| 2016 | 1.04 Billion CNY | 3.48% |
| 2015 | 1 Billion CNY | 49.45% |
| 2014 | 673.21 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 8.94 Billion CNY | -24.79% |
| 2024 Q3 | 9.54 Billion CNY | 6.76% |
| 2024 Q1 | 11.88 Billion CNY | -7.47% |
| 2023 Q3 | 9.74 Billion CNY | -3.31% |
| 2023 Q4 | 12.84 Billion CNY | 31.77% |
| 2023 FY | 12.84 Billion CNY | 33.09% |
| 2023 Q2 | 10.08 Billion CNY | 3.17% |
| 2023 Q1 | 9.77 Billion CNY | 1.25% |
| 2022 Q3 | 9.16 Billion CNY | 5.62% |
| 2022 FY | 9.65 Billion CNY | 19.26% |
| 2022 Q4 | 9.65 Billion CNY | 5.31% |
| 2022 Q1 | 8.31 Billion CNY | 2.75% |
| 2022 Q2 | 8.67 Billion CNY | 4.35% |
| 2021 Q3 | 7.63 Billion CNY | 1.3% |
| 2021 Q1 | 3.6 Billion CNY | 21.34% |
| 2021 Q4 | 8.09 Billion CNY | 6.05% |
| 2021 Q2 | 7.53 Billion CNY | 108.72% |
| 2021 FY | 8.09 Billion CNY | 172.06% |
| 2020 FY | 2.97 Billion CNY | 41.87% |
| 2020 Q1 | 1.35 Billion CNY | -35.34% |
| 2020 Q2 | 1.77 Billion CNY | 30.89% |
| 2020 Q3 | 1.95 Billion CNY | 10.23% |
| 2020 Q4 | 2.97 Billion CNY | 52.06% |
| 2019 Q4 | 2.09 Billion CNY | -16.23% |
| 2019 FY | 2.09 Billion CNY | -8.17% |
| 2019 Q3 | 2.5 Billion CNY | 2.97% |
| 2019 Q2 | 2.43 Billion CNY | 5.22% |
| 2019 Q1 | 2.31 Billion CNY | 1.17% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 2.28 Billion CNY | 19.63% |
| 2018 Q2 | 2.13 Billion CNY | 0.0% |
| 2018 Q3 | 2.23 Billion CNY | 4.62% |
| 2018 Q4 | 2.28 Billion CNY | 2.07% |
| 2017 Q4 | 1.9 Billion CNY | 0.0% |
| 2017 FY | 1.9 Billion CNY | 83.35% |
| 2016 FY | 1.04 Billion CNY | 3.48% |
| 2015 FY | 1 Billion CNY | 49.45% |
| 2014 FY | 673.21 Million CNY | 0.0% |